Share chart Sana Biotechnology, Inc.
Extended chart
Simple chart
About Sana Biotechnology, Inc.
Sana Biotechnology, Inc., биотехнологическая компания, специализируется на использовании искусственных клеток в качестве лекарств. Компания разрабатывает платформы клеточной инженерии in vivo и ex vivo для различных терапевтических областей с неудовлетворенными потребностями в лечении, включая онкологию, диабет, расстройства центральной нервной системы, сердечно-сосудистые заболевания, генетические нарушения и другие. Sana Biotechnology, Inc. ранее была известна как FD Therapeutics, Inc. и сменила свое название на Sana Biotechnology, Inc. в сентябре 2018 года. Компания была зарегистрирована в 2018 году со штаб-квартирой в Сиэтле, штат Вашингтон.Main settings
IPO date
2021-02-04
ISIN
US7995661045
Industry
Biotechnology
Sector
Health Care
Валюта
usd
Валюта отчета
usd
Див.доход ао
0
Сайт
Grade
Underestimation
Title | Value | Grade |
P/S | 0 | 0 |
P/BV | 1.5 | 8 |
P/E | 0 | 0 |
Efficiency
Title | Value | Grade |
ROA | -50.03 | 0 |
ROE | -99.17 | 0 |
ROIC | -23.52 | 0 |
Dividends
Title | Value | Grade |
Dividend yield | 0 | 0 |
DSI | 0 | 0 |
Average dividend growth | 0 | 0 |
Debt
Title | Value | Grade |
Debt/EBITDA | -0.3749 | 10 |
Debt/Ratio | 0.188 | 10 |
Debt/Equity | 1 | 8 |
Growth impulse
Title | Value | Grade |
Yield Revenue, % | 0 | 0 |
Yield Ebitda, % | -10.33 | 0 |
Yield EPS, % | -29.12 | 0 |
Prices
Price | Min. | Max. | Change | Changes in the industry | Changes in the index | |
Yesterday | 2.54 $ | 0 $ | 0 $ | -0.1969 % | 0 % | 0 % |
Week | 2.84 $ | 0 $ | 0 $ | -10.74 % | 0 % | 0 % |
Month | 2 $ | 0 $ | 0 $ | +26.75 % | 0 % | 0 % |
Three month | 1.55 $ | 1.59 $ | 2.91 $ | +63.55 % | 0 % | 0 % |
Half a year | 3.17 $ | 1.34 $ | 3.5 $ | -20.03 % | 0 % | 0 % |
Year | 5.78 $ | 1.34 $ | 6.4 $ | -56.14 % | 0 % | 0 % |
3 years | 6.23 $ | 1.34 $ | 11.27 $ | -59.31 % | 0 % | 0 % |
5 years | 1.34 $ | 1.34 $ | 43.5 $ | +189.18 % | 0 % | 0 % |
10 years | 1.34 $ | 1.34 $ | 43.5 $ | +189.18 % | 0 % | 0 % |
Year to date | 3.49 $ | 1.34 $ | 4.3 $ | -27.36 % | 0 % | 0 % |
Insider trading
Main owners
Contained in ETF
ETF | Share, % | Profitability for 1 year, % | Commission, % |
Future Tech ETF | 0.0919 | 479.5 | 0.35 |
Principal Healthcare Innovators ETF | 0.0919 | -3.92 | 0.35 |
iShares Morningstar Small-Cap Growth ETF | 0.01678 | 570.49 | 0.06 |
iShares Morningstar Small-Cap ETF | 0.01096 | 301.34 | 0.25 |
iShares Morningstar Small-Cap Value ETF | 0.00549 | 175.74 | 0.06 |
0.04 | 304.63 | 0.21 |
---|
Similar companies
P/E & P/BV
Company management
Head | Job title | Payment | Year of birth |
Mr. Nathan Hardy M.B.A. | Executive VP & CFO | 683.49k | 1976 (49 years) |
Dr. Edward Rebar Ph.D. | Head of Cell Engineering | N/A | 1968 (57 years) |
Ms. Robin Andrulevich | Executive VP & Chief People Officer | N/A | 1966 (59 years) |
Dr. Steven D. Harr M.D. | President, CEO & Director | 1.04M | 1970 (55 years) |
Mr. Paul Brunetta M.D. | Senior VP and Head of Clinical & Translational Science | N/A | |
Mr. Bernard J. Cassidy J.D. | Executive VP, General Counsel & Corporate Secretary | 491.39k | 1955 (70 years) |
Mr. Christian Hordo M.B.A. | Executive VP & Chief Business Officer | 485.03k | 1983 (42 years) |
Dr. Sonja Schrepfer M.D., Ph.D. | Senior VP & Head of Hypoimmune Platform | N/A | 1975 (50 years) |
Mr. Snehal Patel | Senior VP & Chief Technical Officer | ||
Dr. Dhavalkumar D. Patel M.D., Ph.D. | Executive VP & Chief Scientific Officer | 1961 (64 years) |
About company
Address: United States, Seattle, 188 East Blaine Street - Open in google maps, Open in yandex maps
Website: https://www.sana.com
Website: https://www.sana.com